IGF1 and diabetes mellitus: Indeed IGF-1 mRNA has been found to be reduced in the eye in early stages of clinical and experimental diabetes [135], while IGF replacement therapy counteracts proapoptotic abnormalities preceding retinal cell degeneration in diabetic rats [136].